Cargando…
Bifunctional ligand design for modulating mutant p53 aggregation in cancer
Protein misfolding and aggregation contributes to the development of a wide range of diseases. In cancer, over 50% of diagnoses are attributed to p53 malfunction due to missense mutations, many of which result in protein misfolding and accelerated aggregation. p53 mutations also frequently result in...
Autores principales: | Miller, Jessica J., Blanchet, Anaïs, Orvain, Christophe, Nouchikian, Lucienne, Reviriot, Yasmin, Clarke, Ryan M., Martelino, Diego, Wilson, Derek, Gaiddon, Christian, Storr, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006507/ https://www.ncbi.nlm.nih.gov/pubmed/32055386 http://dx.doi.org/10.1039/c9sc04151f |
Ejemplares similares
-
Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair
por: Blanchet, Anais, et al.
Publicado: (2021) -
Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer
por: Venkatasamy, Aina, et al.
Publicado: (2021) -
Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities
por: Chen, Hongshan, et al.
Publicado: (2007) -
Bifunctional crosslinking ligands for transthyretin
por: Mangione, P. Patrizia, et al.
Publicado: (2015) -
Treating p53 Mutant Aggregation-Associated Cancer
por: Kanapathipillai, Mathumai
Publicado: (2018)